{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-19T12:32:18.206420+00:00","company":{"ticker":"APTN","cik":1938571,"company_name":"ADAPTIN BIO, INC."},"pagination":{"limit":100,"returned":8,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"ma_counterparty":[{"display_name":"Adaptin Bio, Inc.","detail":"acquisition","count":2,"first_seen":"2025-02-18T23:59:59+00:00","last_seen":"2025-02-18T23:59:59+00:00","evidence_fact_ids":[95428,95429]},{"display_name":"Unite Acquisition 1 Corp.","detail":"change_of_control","count":1,"first_seen":"2025-04-15T23:59:59+00:00","last_seen":"2025-04-15T23:59:59+00:00","evidence_fact_ids":[85814]}]},"facts":[{"fact_type":"equity_issuance","fact_key":"d92d7709a2cba78959e0c0f0bea2a67c063fb8ce","cik":1938571,"ticker":"APTN","company_name":"ADAPTIN BIO, INC.","filed_at":"2025-12-23T23:59:59+00:00","payload":{"action":"private_placement","consideration_text":"$5.00 per Share for gross proceeds of $1.0 million","effective_date":"2025-12-22","item_codes_triggered":["3.02"],"purchaser":"certain investors","security_type":"common_stock","shares_text":"200,000 shares"},"claim":"ADAPTIN BIO, INC. issued 200,000 shares of common stock to certain investors for $5.00 per Share for gross proceeds of $1.0 million.","evidence_excerpt":"On December 22, 2025, Adaptin Bio, Inc. (the “Company”) entered into a subscription agreement (the “Subscription Agreement”) with certain investors and sold 200,000 shares (the “Shares”) of the Company’s common stock (the “Common Stock”) at $5.00 per Share for gross proceeds of $1.0 million in a closing of a private placement offering (the “Offering”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-125451","anchor_url":"https://secwatch.observer/filing/0001213900-25-125451#claim-d92d7709a2cba78959e0c0f0bea2a67c063fb8ce","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025125451/0001213900-25-125451-index.htm"},{"fact_type":"ma_transaction","fact_key":"d3216e476a42a18cfb8d05ced89cc52fc7c8d6c7","cik":1938571,"ticker":"APTN","company_name":"ADAPTIN BIO, INC.","filed_at":"2025-04-15T23:59:59+00:00","payload":{"action":"change_of_control","closing_date":null,"consideration_text":null,"counterparty":"Unite Acquisition 1 Corp.","effective_date":null,"item_codes_triggered":["2.01","5.01"]},"claim":"ADAPTIN BIO, INC. underwent a change of control involving Unite Acquisition 1 Corp..","evidence_excerpt":"the completion of the Merger (as defined in the Original Report)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-031875","anchor_url":"https://secwatch.observer/filing/0001213900-25-031875#claim-d3216e476a42a18cfb8d05ced89cc52fc7c8d6c7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025031875/0001213900-25-031875-index.htm"},{"fact_type":"governance_change","fact_key":"ce7ed941bb0804695e05ea1c721cee5613684310","cik":1938571,"ticker":"APTN","company_name":"ADAPTIN BIO, INC.","filed_at":"2025-02-18T23:59:59+00:00","payload":{"change_type":"shell_status","effective_date":null,"item_codes_triggered":["5.06"],"summary_text":"Registrant ceased to be a shell company as a result of the Merger."},"claim":"ADAPTIN BIO, INC.: Registrant ceased to be a shell company as a result of the Merger.","evidence_excerpt":"As a result of the Merger, we have ceased to be a shell company.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-014630","anchor_url":"https://secwatch.observer/filing/0001213900-25-014630#claim-ce7ed941bb0804695e05ea1c721cee5613684310","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025014630/0001213900-25-014630-index.htm"},{"fact_type":"governance_change","fact_key":"b06e226122532ff4c554a2becf139147b4c89275","cik":1938571,"ticker":"APTN","company_name":"ADAPTIN BIO, INC.","filed_at":"2025-02-18T23:59:59+00:00","payload":{"change_type":"code_of_ethics","effective_date":null,"item_codes_triggered":["5.05"],"summary_text":"Board adopted a new Code of Ethics in connection with the Merger, applying to all directors, officers, and employees."},"claim":"ADAPTIN BIO, INC.: Board adopted a new Code of Ethics in connection with the Merger, applying to all directors, officers, and employees.","evidence_excerpt":"In connection with the Merger, the board of directors adopted a new Code of Ethics, which applies to all directors, officers (including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions) and employees.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-014630","anchor_url":"https://secwatch.observer/filing/0001213900-25-014630#claim-b06e226122532ff4c554a2becf139147b4c89275","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025014630/0001213900-25-014630-index.htm"},{"fact_type":"governance_change","fact_key":"fcaa67af5c65077254ec04150f61e6ee05f7cea0","cik":1938571,"ticker":"APTN","company_name":"ADAPTIN BIO, INC.","filed_at":"2025-02-18T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":null,"item_codes_triggered":["5.03"],"summary_text":"Bylaws amended and restated in their entirety effective upon closing of the Merger."},"claim":"ADAPTIN BIO, INC.: Bylaws amended and restated in their entirety effective upon closing of the Merger.","evidence_excerpt":"Prior to the Merger, we amended and restated our bylaws in their entirety, to be effective upon closing of the Merger.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-014630","anchor_url":"https://secwatch.observer/filing/0001213900-25-014630#claim-fcaa67af5c65077254ec04150f61e6ee05f7cea0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025014630/0001213900-25-014630-index.htm"},{"fact_type":"governance_change","fact_key":"a475e7c0bfa39174722403e4f60ae500b93cde63","cik":1938571,"ticker":"APTN","company_name":"ADAPTIN BIO, INC.","filed_at":"2025-02-18T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-02-11","item_codes_triggered":["5.03"],"summary_text":"Amendment and restatement of certificate of incorporation approved by board on February 11, 2025 and by stockholders on the same date, effective upon the Merger."},"claim":"ADAPTIN BIO, INC.: Amendment and restatement of certificate of incorporation approved by board on February 11, 2025 and by stockholders on the same date, effective upon the Merger (effective 2025-02-11).","evidence_excerpt":"Prior to the Merger, Unite Acquisition’s board of directors approved the amendment and restatement of our certificate of incorporation on February 11, 2025, and stockholders holding 100% of the then outstanding shares of our Common Stock approved the amendment and restatement to our certificate of incorporation on February 11, 2025.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-014630","anchor_url":"https://secwatch.observer/filing/0001213900-25-014630#claim-a475e7c0bfa39174722403e4f60ae500b93cde63","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025014630/0001213900-25-014630-index.htm"},{"fact_type":"ma_transaction","fact_key":"1532607139797f7c538128d5377425e8b9ebe2af","cik":1938571,"ticker":"APTN","company_name":"ADAPTIN BIO, INC.","filed_at":"2025-02-18T23:59:59+00:00","payload":{"action":"change_of_control","closing_date":"2025-02-11","consideration_text":null,"counterparty":"Adaptin Bio, Inc. (Private Adaptin)","effective_date":"2025-02-11","item_codes_triggered":["5.01"]},"claim":"ADAPTIN BIO, INC. underwent a change of control involving Adaptin Bio, Inc. (Private Adaptin) (closed 2025-02-11).","evidence_excerpt":"As a result of the Merger, we acquired the business of Private Adaptin and will continue its business operations as a public reporting company under the same name, Adaptin Bio, Inc.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-014630","anchor_url":"https://secwatch.observer/filing/0001213900-25-014630#claim-1532607139797f7c538128d5377425e8b9ebe2af","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025014630/0001213900-25-014630-index.htm"},{"fact_type":"ma_transaction","fact_key":"e6b2cae5bf50a1056d465fbaa7f7cf480c63d7bd","cik":1938571,"ticker":"APTN","company_name":"ADAPTIN BIO, INC.","filed_at":"2025-02-18T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2025-02-11","consideration_text":null,"counterparty":"Adaptin Bio, Inc. (Private Adaptin)","effective_date":"2025-02-11","item_codes_triggered":["2.01","5.01"]},"claim":"ADAPTIN BIO, INC. completed an acquisition involving Adaptin Bio, Inc. (Private Adaptin) (closed 2025-02-11).","evidence_excerpt":"On February 11, 2025, Unite Acquisition’s wholly-owned subsidiary, Adaptin Acquisition Co., a Delaware corporation formed in the State of Delaware on January 30, 2025 (“Merger Sub”), merged with and into Adaptin Bio, Inc., a privately held Delaware corporation (“Private Adaptin”) formerly known as Centaur Bio Inc.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-014630","anchor_url":"https://secwatch.observer/filing/0001213900-25-014630#claim-e6b2cae5bf50a1056d465fbaa7f7cf480c63d7bd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025014630/0001213900-25-014630-index.htm"}]}